Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2024 Jul 5;43:186. doi: 10.1186/s13046-024-03112-w

Correction: Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma

Fei Xiong 1,2,#, Da Wang 1,#, Wei Xiong 3,#, Xin Wang 4, Wen-hua Huang 5, Guan-hua Wu 1, Wen-zheng Liu 1, Qi Wang 1, Jun-sheng Chen 1, Yi-yang Kuai 1, Bing Wang 1,, Yong-jun Chen 1,
PMCID: PMC11225322  PMID: 38965576

Correction: J Exp Clin Cancer Res 43, 152 (2024)

10.1186/s13046-024-03070-3.

Following publication of the original article [1], the authors would like to add another affiliation to Fei Xiong. Tongji Hospital where he graduated has to be added to his affiliation details. The revised affiliations are shown below:

Fei Xiong1,2†, Da Wang1†, Wei Xiong3†, Xin Wang4, Wen-hua Huang5, Guan-hua Wu1, Wen-zheng Liu1, Qi Wang1, Jun-sheng Chen1, Yi-yang Kuai1, Bing Wang1* and Yong-jun Chen1*.

The correction does not affect the overall result or conclusion of the article. The original article has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s13046-024-03070-3.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Fei Xiong, Da Wang and Wei Xiong contributed equally to this work.

References

  • 1.Xiong F, Wang D, Xiong W, et al. Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma. J Exp Clin Cancer Res. 2024;43:152. doi: 10.1186/s13046-024-03070-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES